News
Potential Amedisys, Inc. (NASDAQ:AMED) shareholders may wish to note that the Lead Independent Director, Richard Lechleiter ... by the Independent Director, Bruce Perkins, for US$2.1m worth ...
Former Eli Lilly and Co. CEOs Randall Tobias and John Lechleiter, with their wives Deborah and Sarah, respectively, have partnered to commit a combined $20 million gift to create the Tobias ...
Consider recent history: When he got the job at the beginning of this year, Lechleiter could fairly have expected to inherit the position just in time for Lilly's new blood-thinner, Effient to hit ...
Lechleiter, Director at Nike (NYSE: NKE). Lechleiter's average cost works out to $100.34/share. In trading on Tuesday, bargain hunters could buy shares of Nike (NYSE: NKE) and achieve a cost basis ...
INDIANAPOLIS — Former Eli Lilly and Co. CEOs John Lechleiter and Randall Tobias, and their wives Deborah and Sarah, have partnered on a $20 million gift to establish the Tobias-Lechleiter Institute ...
"The sweet spot for me, in terms of knowledge of this business, is drug development," Dr. John Lechleiter said in a phone interview with CNNMoney.com. Lechleiter is currently Lilly's chief ...
Eli Lilly & Co. Chairman and Chief Executive Officer John Lechleiter returned to his positions full-time following surgery to repair a heart defect in May. The procedure and recovery were ...
INDIANAPOLIS (WTHR) - Eli Lilly and company announced Wednesday that President and CEO John C. Lechleiter will retire at the end of this year. Lechleiter has been the company's CEO since April 1, 2008 ...
Former Eli Lilly and Co. CEOs John Lechleiter and Randall Tobias, and their wives Deborah and Sarah, have partnered on a $20 million gift to establish the Tobias-Lechleiter Institute for Clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results